Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

ACADIA Pharmaceuticals, Inc. (ACAD) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

ACADIA Pharmaceuticals is a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders. The company’s pipeline of product includes pimavanserin, which is in phase 3 development as a potential first-in-class … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Verisante Technology, Inc. (VRS) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Verisante Technology produces coated papers, including coated groundwood and coated freesheet, and specialty paper products, for use primarily in media and marketing applications, including magazines, catalogs and commercial printing applications such as high-end advertising brochures, annual reports and direct-mail advertising. … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Hemispherx Biopharma, Inc. (HEB) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Hemispherx Biopharma is a specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. The company’s flagship products include Alferon N Injection(R) (FDA approved for a category of sexually transmitted … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

MediciNova, Inc. (MNOV) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

MediciNova is a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet need with a commercial focus on the U.S. market. MNOV’s portfolio of clinical and preclinical product candidates includes six clinical-stage … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Reed’s, Inc. (REED) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Reed’s manufactures natural sodas in the natural foods industry. The company owns the Virgil’s Root Beer product line and the China Cola product line, and in 2012 launched Reed’s Culture Club Kombucha line of organic live beverages. Other product lines … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Local.com Corp. (LOCM) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Local.com is a national online media company that connects merchants and consumers. Leveraging its technology platforms, the company provides business solutions such as digital marketing products and tools such as local business and product search, mobile, SEO, Web hosting, social … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Cytosorbents Corp. (CTSO) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Cytosorbents is a therapeutic device company that uses blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses. In 2011, the company’s CytoSorb® was approved in the European Union as a cytokine filter to be used … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

World Energy Solutions, Inc. (XWES) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

World Energy Solutions is an energy management services firm providing a range of energy management solutions to commercial and industrial businesses, institutions, utilities and governments. The company primarily focuses on retail and wholesale energy procurement clients via its online auction … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

AspenBio Pharma, Inc. (APPY) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

AspenBio Pharma is an in vitro diagnostic company focused on the clinical development and commercialization of its lead product AppyScore, a blood-based test designed to aid in the identification of patients at low risk for acute appendicitis. APPY is focused … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Virtual Piggy, Inc. (VPIG) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Virtual Piggy is a technology company delivering online solutions for parents and merchants to provide a tool to address these issues and is designed to provide a secure mechanism by which children can make purchases online in a manner that … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment